Cost utility analysis of immunosuppressive regimens in adult renal transplant recipients in England and Wales

Gorden Muduma,1 Jane Shaw,2 Warren M Hart,3 Abayomi Odeyemi,3 Isaac Odeyemi21Astellas Pharma Europe Limited, Chertsey, UK; 2Astellas Pharma Limited, Chertsey, UK; 3EcoStat Consulting UK Limited, London, UKBackground: End-stage renal disease is the irreversible final stage of chronic kidney disease a...

Full description

Bibliographic Details
Main Authors: Muduma G, Shaw J, Hart WM, Odeyemi A, Odeyemi I
Format: Article
Language:English
Published: Dove Medical Press 2014-11-01
Series:Patient Preference and Adherence
Online Access:http://www.dovepress.com/cost-utility-analysis-of-immunosuppressive-regimens-in-adult-renal-tra-peer-reviewed-article-PPA